$0.3940
0.03389.38%
Last update: Nov 9, 7:58 PM
Tenaya Therapeutics Inc
TNYANASDAQ
Tenaya Therapeutics (TNYA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.10 | $-0.07 | $-0.09 | $-0.12 |
| Actual | $-0.08 | $-0.20 | $-0.09 | $-0.12 |
| Surprise | +20.0% | -185.7% | 0.00% | 0.00% |
| Revenue | ||||
| Estimate | $850000 | $10.0M | $8.0M | — |
| Actual | $1.7M | $1.1M | $25.0M | — |
| Surprise | +99.7% | -88.9% | +212.5% | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.09 | $-0.08 | $-0.08 | $-0.08 |
| Revenue | ||||
| Consensus | $1.6M | $1.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.08 | $-0.10 | 20.0 % |
| Q2 | Aug 5, 2026 | $-0.20 | $-0.07 | -185.7 % |
| Q1 | May 6, 2026 | $-0.09 | $-0.09 | 0.00 % |
| Q4 | Mar 11, 2026 | $-0.12 | $-0.12 | 0.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $1.70M | $850.00K | 99.7 % |
| Q2 | Aug 5, 2026 | $1.11M | $10.00M | -88.9 % |
| Q1 | May 6, 2026 | $25.00M | $8.00M | 212.5 % |
| Q4 | Mar 10, 2025 | $0 | $1.00M | -100.0 % |
